Company Data
ATAI Life Sciences N.V.
Ticker
ATAI
Current Price
$1.85 -3.14%
Market Cap
$307.1M
Price Target
Refer to Report
Volume
941.1K
52wk Range
$1.025 - $2.85
Overview
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine.